51389-37-8 Usage
Molecular structure
The compound has a purine base structure with three methyl groups at the 1, 3, and 7 positions, and a phenylethynyl moiety at the 8 position.
Phenylethynyl group substitution
The phenylethynyl group is substituted with three methoxy groups at the 2, 3, and 4 positions.
Potential pharmacological properties
Due to its unique molecular structure, the compound may have potential pharmacological properties or applications.
Organic synthesis applications
The compound may also have potential uses in organic synthesis.
Further research needed
Further research and evaluation of this compound are required to fully understand its properties and potential uses.
Molecular weight
The molecular weight of the compound is approximately 420.45 g/mol.
Stereochemistry
The compound has a (E)-configuration at the phenylethynyl moiety, indicating that the double bond has a trans configuration.
Solubility
The solubility of the compound in various solvents is not provided in the material, but it may be influenced by its molecular structure and functional groups.
Stability
The stability of the compound under different conditions (e.g., temperature, pH, light exposure) is not provided in the material, but it may be affected by its molecular structure and functional groups.
Check Digit Verification of cas no
The CAS Registry Mumber 51389-37-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,3,8 and 9 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 51389-37:
(7*5)+(6*1)+(5*3)+(4*8)+(3*9)+(2*3)+(1*7)=128
128 % 10 = 8
So 51389-37-8 is a valid CAS Registry Number.
51389-37-8Relevant articles and documents
Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists
Jacobson,Gallo-Rodriguez,Melman,Fischer,Maillard,Van Bergen,Van Galen,Karton
, p. 1333 - 1342 (2007/10/02)
A series of substituted 8-styryl derivatives of 1,3,7-alkylxanthines was synthesized as potential A2-selective adenosine receptor antagonists, and the potency at rat brain A1- and A2-receptors was studied in radioligand bi